Biomechanical and Morphological Characterization of PTTD

NCT ID: NCT06260813

Last Updated: 2025-04-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-08-22

Study Completion Date

2028-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Posterior tibial tendon dysfunction (PTTD) is a progressive condition of the tendon of the tibialis posterior muscle with symptoms of tendinopathy or even rupture. Functionally, it is associated with the inability to lock the mid foot and thus manifests itself as a main contributor to adult acquired flatfoot deformity.

Concerning treatment, clinical decision making is currently based on a classification integrating various parameters as pain, flexibility of the foot joints, the condition of the posterior tibial tendon assessed through ultrasound imaging and radiographic assessment of arthritic changes. Surprisingly, this classification does not consider any morphologic characteristics (the shape of a bone or joint) or functional, biomechanical characteristics of the foot and ankle, i.e. based on kinematics (e.g. range of motion) and/or kinetics (center of pressure, angular velocity, moment, power absorption and power generation of a joint).

Detailed biomechanical characteristics of the foot and ankle can be reliably collected by instrumented gait analysis wherein a 3D camera system is combined with a force plate and plantar pressure platform. Kinematic studies in the field of PTTD typically considered the foot as a structure consisting of three segments: hind foot, forefoot and hallux. Consequently, the mid foot segment (the Chopart and Lisfranc joints) has been neglected, although it is this segment that is particularly affected in PTTD patients.

The aim of this research is to overcome the limitations of the current classification system and treatment of PTTD patients, by complementing the current standard-of-care clinical assessment with better insight in the pathologic changes that occur in PTTD patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Posterior tibial tendon dysfunction (PTTD) is a progressive condition of the tendon of the tibialis posterior muscle with symptoms of tendinopathy or even rupture. Functionally, it is associated with the inability to lock the mid foot and thus manifests itself as a main contributor to adult acquired flatfoot deformity. Importantly, this condition is associated with severe pain, inability to walk, collapse of the foot arch and dislocation and destruction of foot joints, causing serious disability with respect to activities of daily living and professional activities.

Concerning treatment, clinical decision making is currently based on a classification integrating various parameters as pain, flexibility of the foot joints, the condition of the posterior tibial tendon assessed through ultrasound imaging and radiographic assessment of arthritic changes. PTTD stage 1 is characterized by tendinopathy and is suggested to be mainly treated conservatively. Stage 2 is characterized by a flexible flat foot deformation, mostly combined with a tear of the posterior tibial tendon. Here, treatment is suggested through osteotomies and soft tissue surgery. Stage 3 encompasses a rigid flat foot deformity associated with a fully dysfunctional posterior tibial tendon and degenerative changes of the hind foot joints. At this stage fusion of the affected joints should be considered. During recent decades, this classification has been extended with additional subgroups as well as a stage 4 which adds onto stage 3 with excessive tibio-talar valgus and is mainly treated by a complementary fusion of the ankle joint.

Surprisingly, this classification does not consider any morphologic characteristics (the shape of a bone or joint) or functional, biomechanical characteristics of the foot and ankle, i.e. based on kinematics (e.g. range of motion) and/or kinetics (center of pressure, angular velocity, moment, power absorption and power generation of a joint).

Detailed biomechanical characteristics of the foot and ankle can be reliably collected by instrumented gait analysis wherein a 3D camera system is combined with a force plate and plantar pressure platform. Kinematic studies in the field of PTTD typically considered the foot as a structure consisting of three segments: hind foot, forefoot and hallux. Consequently, the mid foot segment (the Chopart and Lisfranc joints) has been neglected, although it is this segment that is particularly affected in PTTD patients. While kinematic studies focus on joint motion, kinetic studies focus on the loading and impact associated with motion of the joints.

Besides documenting specific biomechanical characteristics of the different stages of PTTD, it is essential to explore the relation of these biomechanical characteristics with the bone morphology of the involved osseous structures.

The aim of this research is to overcome the limitations of the current classification system and treatment of PTTD patients, by complementing the current standard-of-care clinical assessment with better insight in the pathologic changes that occur in PTTD patients. This will be done by simultaneously acquiring kinematic, kinetic and morphologic characteristics in PTTD patients, with a special interest in the possible connection between these morphological and the biomechanics changes. Through these insights, we will be able to better classify these patients, using the developed biomechanical classification, as a first step towards an optimized, patient-tailored treatment plan which converts these individual pathological characteristics back to normal, giving the patients back their mobility and a live without pain, i.e. gaining back their quality of life.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Posterior Tibial Tendon Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Prospective interventional study that includes PTTD patients (PTTD I, II and III) and a healthy control group.
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

SINGLE

Participants
PTTD patients (PTTD I, II and III) and a healthy control group.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PTTD patients (PTTD I, II and III)

75 patients with PTTD (25 patients in Stage I, 25 patients in Stage II, 25 patients in Stage III)

Group Type EXPERIMENTAL

Radiography

Intervention Type DIAGNOSTIC_TEST

X-rays of the ankle; anterior-posterior, lateral, Mortise view and hindfoot alignment view. Standard weight bearing x-rays of the foot; anterior-posterior, lateral and oblique view.

Ultrasound

Intervention Type DIAGNOSTIC_TEST

Ultrasound of the posterior tibial tendon to see if there is an irritation, elongation or rupture.

MRI

Intervention Type DIAGNOSTIC_TEST

MRI when ultrasound is not conclusive to identify an irritation, elongation or rupture of the posterior tibial tendon.

CT-scan

Intervention Type DIAGNOSTIC_TEST

CT-scan to identify arthritis of the tibial-talar, subtalar and/or Chopart joints.

Gait analysis

Intervention Type DIAGNOSTIC_TEST

This lab is equipped with a 10-meter walkway surrounded by a passive optoelectronic motion analysis system consisting of 10 cameras to track the motion of markers. In the middle of the walkway, a force plate is integrated, with a pressure plate placed on top.

Healthy control group

25 healthy volunteers

Group Type EXPERIMENTAL

Radiography

Intervention Type DIAGNOSTIC_TEST

X-rays of the ankle; anterior-posterior, lateral, Mortise view and hindfoot alignment view. Standard weight bearing x-rays of the foot; anterior-posterior, lateral and oblique view.

CT-scan

Intervention Type DIAGNOSTIC_TEST

CT-scan to identify arthritis of the tibial-talar, subtalar and/or Chopart joints.

Gait analysis

Intervention Type DIAGNOSTIC_TEST

This lab is equipped with a 10-meter walkway surrounded by a passive optoelectronic motion analysis system consisting of 10 cameras to track the motion of markers. In the middle of the walkway, a force plate is integrated, with a pressure plate placed on top.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Radiography

X-rays of the ankle; anterior-posterior, lateral, Mortise view and hindfoot alignment view. Standard weight bearing x-rays of the foot; anterior-posterior, lateral and oblique view.

Intervention Type DIAGNOSTIC_TEST

Ultrasound

Ultrasound of the posterior tibial tendon to see if there is an irritation, elongation or rupture.

Intervention Type DIAGNOSTIC_TEST

MRI

MRI when ultrasound is not conclusive to identify an irritation, elongation or rupture of the posterior tibial tendon.

Intervention Type DIAGNOSTIC_TEST

CT-scan

CT-scan to identify arthritis of the tibial-talar, subtalar and/or Chopart joints.

Intervention Type DIAGNOSTIC_TEST

Gait analysis

This lab is equipped with a 10-meter walkway surrounded by a passive optoelectronic motion analysis system consisting of 10 cameras to track the motion of markers. In the middle of the walkway, a force plate is integrated, with a pressure plate placed on top.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient groups:

* Posterior tibial tendon dysfunction (all clinical stages)
* Age 18-675 year
* ICF obtained
* Control group:

* No pain complaints
* No pes plano valgus, PTTD or pes cavo varus or other foot and ankle pathology
* Age 18-75 year
* ICF obtained

Exclusion Criteria

* Being younger than 18 years
* Inability to walk without mobility aids
* Inability to walk \< 100 meter
* Difference in leg length \> 3cm
* Subjects with BMI\>30 kg/m², due to less accurate gait analysis by absence of anatomical landmarks
* Subjects unable to perform a gait analysis
* Any medical condition possibly affecting normal gait.
* Pregnancy: at the start or during the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universitaire Ziekenhuizen KU Leuven

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sander Wuite

Role: PRINCIPAL_INVESTIGATOR

Universitaire Ziekenhuizen KU Leuven

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UZ Leuven

Leuven, Vlaams-Brabant, Belgium

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sander Wuite

Role: CONTACT

+32 16 33 83 29

Kevin Deschamps

Role: CONTACT

+32 16 33 88 27

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sander Wuite

Role: primary

+32 16 33 83 29

Kevin Deschamps

Role: backup

+32 16 33 88 27

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

S66277

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.